{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:45:00Z","timestamp":1765539900404,"version":"3.48.0"},"reference-count":38,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-alcoholic Fatty Liver Disease (NAFLD) is one of the diseases that have evolved lately into a major challenge for gastroenterologists. Although, the term NAFLD has not been familiar to the medical world since long, other conditions resembling the presentation of NAFLD have been there since primitive times. It is a reversible condition of the liver, wherein large vacuoles of triglyceride fat accumulates in liver cells via the process of steatosis, despite any evidence of excessive alcohol consumption. In the developed countries NAFLD is reported to be the most common liver disorder, with a worldwide prevalence of 6\u201335%, in India its prevalence has been increasing gradually. Unani physicians have described liver as one of the principal organs of the body. It is the primary source of natural faculties, where the functions of digestion, concoction, absorption and excretion are performed, normally temperament of liver is hot and moist which can get converted to cold due to mutable dietary habits, consumption of fatty and cold food in abundance etc. In Unani System of Medicine, NAFLD has not been described as such, but it can be studied under\n                    <jats:italic>Su\u2019-i-Miz\u0101j Kabid B\u0101rid<\/jats:italic>\n                    due to correlation of most of the symptoms. Its management mainly consists of elimination of morbid matter which is accumulated in the liver and correction of\n                    <jats:italic>Su\u2019-i-Miz\u0101j Kabid B\u0101rid<\/jats:italic>\n                    by using drugs having opposite temperament (\n                    <jats:italic>Ilaj bil zid<\/jats:italic>\n                    ).\n                  <\/jats:p>","DOI":"10.1515\/jcim-2021-0296","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T17:51:45Z","timestamp":1632333105000},"page":"17-23","source":"Crossref","is-referenced-by-count":1,"title":["Non-alcoholic fatty liver disease\u00a0\u2013 discussed under the light of Unani medicine"],"prefix":"10.1515","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-5831","authenticated-orcid":false,"given":"Mohd","family":"Riyazuddin","sequence":"first","affiliation":[{"name":"Department of Moalajat (Medicine) , National Institute of Unani Medicine (Under Ministry of AYUSH) , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisha","family":"Shahid","sequence":"additional","affiliation":[{"name":"Department of Moalajat (Medicine) , National Institute of Unani Medicine (Under Ministry of AYUSH) , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"2025121209084279441_j_jcim-2021-0296_ref_001","doi-asserted-by":"crossref","unstructured":"Reddy, JK, Rao, MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006;290:G852\u20138. https:\/\/doi.org\/10.1152\/ajpgi.00521.2005.","DOI":"10.1152\/ajpgi.00521.2005"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_002","doi-asserted-by":"crossref","unstructured":"Benedict, M, Zhang, X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol 2017;9:715\u201332. https:\/\/doi.org\/10.4254\/wjh.v9.i16.715.","DOI":"10.4254\/wjh.v9.i16.715"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_003","unstructured":"Nassir, F, Rector, RS, Hammoud, GM, Ibdah, JA. Pathogenesis and prevention of hepatic steatosis. Gastroenterol Hepatol 2015;11:167\u201375."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_004","doi-asserted-by":"crossref","unstructured":"Tomic, D, Kemp, WW, Roberts, SK. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol 2018;30:1103\u201315. https:\/\/doi.org\/10.1097\/MEG.0000000000001235.","DOI":"10.1097\/MEG.0000000000001235"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_005","doi-asserted-by":"crossref","unstructured":"Fabbrini, E, Sullivan, S, Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010;51:679\u201389. https:\/\/doi.org\/10.1002\/hep.23280.","DOI":"10.1002\/hep.23280"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_006","unstructured":"Ibn Rushd, AM. Kitabul Kulliyat, 2nd ed. New Delhi: CCRUM; 1987:26, 35, 46, 49\u201350 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_007","unstructured":"Arzani, HA. Tib e Akbar. (Urdu translation by Hakim Mohammad Hussain). Deoband: Faisal Publications; YNM, vol 2:439\u201342 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_008","unstructured":"IbnZuhr, AM. Kitab al Taiseer, 1st ed. New Delhi: CCRUM; 1986:114 p."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_009","unstructured":"Tabri, AM. Moalajate Buqratiya. New Delhi: CCRUM; 1997, vol 3:202\u201317 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_010","unstructured":"Jurjani, AH. Zakheera KhwarzamShahi. New Delhi: Idara Kitabul Shifa; 2010, vol 6:371-374, 377-381 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_011","unstructured":"Khan, HA. Ikseer e Azam. Urdu translation by Hakim Mohammad Kabeeruddin. New Delhi: Idara Kitabul Shifa; 2011:481\u201398 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_012","unstructured":"Sina, IBN. Al Qanoon Fil Tib. Part 1. New Delhi: Idara Kitabul Shifa; YNM, vol 3:849-852, 854-864 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_013","unstructured":"Shah, MH. The general principles of Avicenna\u2019s Canon of Medicine. Part 1. New Delhi: Idara Kitabul Shifa; 2007, vol 1:30 p."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_014","unstructured":"Al Razi, ABMBZ. Kitab-al Hawi Fit-Tib. New Delhi: CCRUM; 2000:47\u201351 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_015","unstructured":"Khan, HA. Rumuz-e-Azam. New Delhi: CCRUM;YNM, vol 2:3\u20137 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_016","unstructured":"Al Maseehi, ASIBY. Kitabul Mi\u2019aah. New Delhi: CCRUM; 2008, vol 1:56 p."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_017","unstructured":"Zillurrahman, HS. Kitab Fil Mizaj (Jalinoos). Aligarh: IbnSina Academy; 2008:101,102,137, 126\u2013141 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_018","doi-asserted-by":"crossref","unstructured":"de Vries, M, Westerink, J, Kaasjager, KH, de Valk, HW. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metab 2020;105:3842\u201353. https:\/\/doi.org\/10.1210\/clinem\/dgaa575.","DOI":"10.1210\/clinem\/dgaa575"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_019","doi-asserted-by":"crossref","unstructured":"Younossi, ZM, Marchesini, G, Pinto-Cortez, H, Petta, S. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation 2019;103:22\u20137. https:\/\/doi.org\/10.1097\/TP.0000000000002484.","DOI":"10.1097\/TP.0000000000002484"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_020","doi-asserted-by":"crossref","unstructured":"Mitra, S, De, A, Chowdhury, A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol 2020;5:16. https:\/\/doi.org\/10.21037\/tgh.2019.09.08.","DOI":"10.21037\/tgh.2019.09.08"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_021","doi-asserted-by":"crossref","unstructured":"Carr, RM, Oranu, A, Khungar, V. Nonalcoholic fatty liver disease: pathophysiology and management. GastroenterolClin North Am 2016;45:639\u201352. https:\/\/doi.org\/10.1016\/j.gtc.2016.07.003.","DOI":"10.1016\/j.gtc.2016.07.003"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_022","doi-asserted-by":"crossref","unstructured":"Adams, LA, Angulo, P, Lindor, KD. Nonalcoholic fatty liver disease. CMAJ 2005;172:899\u2013905. https:\/\/doi.org\/10.1503\/cmaj.045232.","DOI":"10.1503\/cmaj.045232"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_023","doi-asserted-by":"crossref","unstructured":"Caldwell, SH, Argo, CK. Non-alcoholic fatty liver disease and nutrition. In: Dooley, JS, Lok, ASF, Burroughs, AK, Heathcote, EJ, editors. Sherlock\u2019s diseases of the liver and biliary system, 12th ed. UK: Wiley-Blackwell Publication; 2011:546\u201361 pp.","DOI":"10.1002\/9781444341294.ch28"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_024","unstructured":"Stengel, JZ, Harrison, SA. Nonalcoholic steatohepatitis: clinical presentation, diagnosis, and treatment. Gastroenterol Hepatol 2006;2:440\u20139."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_025","doi-asserted-by":"crossref","unstructured":"Cobbina, E, Akhlaghi, F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 2017;49:197\u2013211. https:\/\/doi.org\/10.1080\/03602532.2017.1293683.","DOI":"10.1080\/03602532.2017.1293683"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_026","doi-asserted-by":"crossref","unstructured":"Kirpich, IA, Marsano, LS, McClain, CJ. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem 2015;48:923\u201330. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.06.023.","DOI":"10.1016\/j.clinbiochem.2015.06.023"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_027","doi-asserted-by":"crossref","unstructured":"Persico, M, Capasso, M, Persico, E, Svelto, M, Russo, R, Spano, D, et al.. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 2007;46:1009\u201315. https:\/\/doi.org\/10.1002\/hep.21782.","DOI":"10.1002\/hep.21782"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_028","unstructured":"Baghdadi, ABH. Mukhtarat Fil Tib. New Delhi: CCRUM; 2004, vol 3:268\u201373 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_029","doi-asserted-by":"crossref","unstructured":"Chalasani, N, Younossi, Z, Lavine, JE, Charlton, M, Cusi, K, Rinella, M, et al.. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005\u201323. https:\/\/doi.org\/10.1002\/hep.25762.","DOI":"10.1002\/hep.25762"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_030","doi-asserted-by":"crossref","unstructured":"Musso, G, Gambino, R, Cassader, M, Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617\u201349. https:\/\/doi.org\/10.3109\/07853890.2010.518623.","DOI":"10.3109\/07853890.2010.518623"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_031","doi-asserted-by":"crossref","unstructured":"Singh, D, Das, CJ, Baruah, MP. Imaging of non-alcoholic fatty liver disease: a road less travelled. Indian J Endocrinol Metab 2013;17:990\u20135. https:\/\/doi.org\/10.4103\/2230-8210.122606.","DOI":"10.4103\/2230-8210.122606"},{"key":"2025121209084279441_j_jcim-2021-0296_ref_032","unstructured":"Adam, A, Dixon, AK, Grainger, RG, Allison, DJ. Grainger & Allison\u2019s diagnostic radiology, 5th ed. China: Elsevier Publication; 2008, vol 1:731\u20132 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_033","unstructured":"Subbarao, K, Banerjee, S, Aggarwal, SK, Bhargava, SK. Diagnostic radiology and imaging, 2nd ed. New Delhi: Jaypee Brothers; 2003, vol 1:495\u20136 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_034","unstructured":"Firdaus, HHAK. Majmaul Behrain. Lucknow: Munshi Naval Kishor;YNM:411\u20133 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_035","unstructured":"Ali, SA. Tarjuma Zakheera Sabit Ibn Qurrah. Aligarh: Lithocolour Printers; 1987:239\u201340 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_036","unstructured":"Al Tabri, ABSR. Firdausal Hikmat. New Delhi: IdaraKitab us Shifa; 2010:207\u2013208, 209 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_037","unstructured":"Khare, CP. Indian medicinal plants- an illustrated dictionary. New Delhi: Rajkamal Electric Press; 2007:63, 178, 191, 271, 284, 586, 694 pp."},{"key":"2025121209084279441_j_jcim-2021-0296_ref_038","unstructured":"Abdul Hakim, HM. Bustanul Mufradat. New Delhi: Idara Kitabul Shifa; 2002:66, 73, 95, 118, 316, 400, 516 pp."}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2021-0296\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2021-0296\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:40:13Z","timestamp":1765539613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2021-0296\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,3]]},"published-print":{"date-parts":[[2023,3,14]]}},"alternative-id":["10.1515\/jcim-2021-0296"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2021-0296","relation":{},"ISSN":["1553-3840"],"issn-type":[{"type":"electronic","value":"1553-3840"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}